0.5 CPD learning hours
Probiotics and Irritable Bowel Syndrome (IBS): Evidence Update and Practical Considerations for Primary Care
Dr Dave Chatoor is a Neurogastro Surgeon at University College London Hospitals NHS Foundation Trust in London, U.K. In this webinar, Dr Dave Chatoor delivers a summary of the current management guidelines for irritable bowel syndrome (IBS), including an overview of the potential of specific probiotic strains including Bifidobacterium longum 35624™ and Bifidobacterium longum 1714™. Dr Chatoor discusses the latest research, alongside reflections of his own clinical experience with individuals with IBS, including practical tips for communicating with individuals regarding their symptoms and management approaches.
- Understand why IBS has been reclassified as a disorder of gut-brain interaction and the implications for its management in clinical settings
- Understand the latest clinical and real world evidence available regarding the use of specific probiotic strains (with a focus upon Bifidobacterium longum strains 35624® and 1714®) as part of the clinical management of IBS symptoms
- Understand how to effectively communicate with individuals with IBS symptoms regarding their symptoms and management plan
Recommended for you…